Search Results 31-40 of 9793 for Inhibition

  1. Carbonic Anhydrase Inhibitor (Oral Route, Parenteral Route) Proper Use - Mayo Clinic

    This medicine may be taken with meals to lessen the chance of stomach upset. However, if stomach upset (nausea or vomiting) continues, check with your ...

  2. Targeting Matrix Metalloproteinases Using Tissue Inhibitors - Proteases in Cancer Laboratory - Mayo Clinic Research

    The Proteases in Cancer Lab of Evette S. Radisky, Ph.D., at Mayo Clinic is developing inhibitors for several MMPs known to promote cancer progression by ...

  3. C1 Esterase Inhibitor, Human (Intravenous Route, Subcutaneous Route) Side Effects - Mayo Clinic

    Check with your doctor or nurse immediately if any of the following side effects occur: More common. Chest pain or tightness; head congestion; hoarseness or ...

  4. Mayo Clinic Q and A: Proton pump inhibitors generally safe when used as directed

    ANSWER: Proton pump inhibitors (PPIs) are the most effective medications for the treatment of chronic acid reflux (gastroesophageal reflux disease, or GERD) and ...

  5. Anti-Inhibitor Coagulant Complex (Intravenous Route) Before Using - Mayo Clinic

    Non-hemophilic patients (who have acquired inhibitors against Factors VIII, IX, or XII)—May increased risk for both bleeding and blood clotting problems.

  6. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial - Mayo Clinic

    A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute ...

  7. Alpha-1 Proteinase Inhibitor Human (Intravenous Route) Description and Brand Names - Mayo Clinic

    Alpha-1 proteinase inhibitor injection, also called alpha 1-PI, is used to treat a certain type of emphysema (a lung condition). The emphysema is caused by the ...

  8. C1 Esterase Inhibitor Recombinant (Intravenous Route) Description and Brand Names - Mayo Clinic

    C1 esterase inhibitor recombinant is used to treat hereditary angioedema (HAE) in adults and teenagers. HAE is a rare disease that causes swelling of the face, ...

  9. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion ...

  10. Development of PARP Inhibitors and DDR Modifiers To Treat Ovarian Cancer - Anticancer Drug Action Laboratory - Mayo Clinic Research

    Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the susceptibility of HR-deficient cancer cells to PARP inhibitors ...